Sign up to save your podcasts
Or
Share iwCLL 2023: The role of continuous BTKis, approaching Richter’s transformation & addressing the underrepresentation of elderly patients in trials
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
iwCLL 2023: The role of continuous BTKis, approaching Richter’s transformation & addressing the underrepresentation of elderly patients in trials
The biennial International Workshop on Chronic Lymphocytic LeukemiaTM (iwCLL 2023) was held recently in Boston, MA, and brought together experts who shared the latest updates in the treatment and management of CLL.
Tune in as we share some key highlights from this year’s meeting. In this podcast, a variety of topics are covered, including the role of continuous BTK inhibitors (BTKis) in CLL, the importance of investigating the biology of Richter’s transformation (RT), and the need to address the underrepresentation of elderly patients in CLL clinical trials. You will hear from several leading experts, including Kerry Rogers, MD, Ohio State University, Columbus, OH, Brian Koffman, MDCM (retired), DCFP, FCFP, DABFP, MSEd, CLL Society, Inc., Chula Vista, CA, Raul Cordoba, MD, PhD, University Hospital Fundación Jiménez Díaz, Madrid, Spain, and Adam Kittai, MD, Ohio State University, Columbus, OH.
The post iwCLL 2023: The role of continuous BTKis, approaching Richter’s transformation & addressing the underrepresentation of elderly patients in trials appeared first on VJHemOnc.
View all episodes
By VJHemOnc
4.5
22 ratings
The biennial International Workshop on Chronic Lymphocytic LeukemiaTM (iwCLL 2023) was held recently in Boston, MA, and brought together experts who shared the latest updates in the treatment and management of CLL.
Tune in as we share some key highlights from this year’s meeting. In this podcast, a variety of topics are covered, including the role of continuous BTK inhibitors (BTKis) in CLL, the importance of investigating the biology of Richter’s transformation (RT), and the need to address the underrepresentation of elderly patients in CLL clinical trials. You will hear from several leading experts, including Kerry Rogers, MD, Ohio State University, Columbus, OH, Brian Koffman, MDCM (retired), DCFP, FCFP, DABFP, MSEd, CLL Society, Inc., Chula Vista, CA, Raul Cordoba, MD, PhD, University Hospital Fundación Jiménez Díaz, Madrid, Spain, and Adam Kittai, MD, Ohio State University, Columbus, OH.
The post iwCLL 2023: The role of continuous BTKis, approaching Richter’s transformation & addressing the underrepresentation of elderly patients in trials appeared first on VJHemOnc.
More shows like VJHemOnc Podcast
View all
Hematologic Oncology Update
70 Listeners
Research To Practice | Oncology Videos
111 Listeners
PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast
12 Listeners
The Hematologist
27 Listeners
The Daily
111,096 Listeners
Up First from NPR
56,020 Listeners
Blood Podcast
56 Listeners
The Ezra Klein Show
15,546 Listeners
The BSH Guidelines Official Podcast
2 Listeners
EHA Unplugged
1 Listeners
The Hematology Podcast Series!
0 Listeners
WolverHeme Happy Hour
29 Listeners
Two Onc Docs
181 Listeners
Blood Cancer Talks
48 Listeners
The HemOnc Pulse
26 Listeners